Discriminative stimulus properties of the atypical antipsychotic amisulpride: comparison to its isomers and to other benzamide derivatives, antipsychotic, antidepressant, and antianxiety drugs in C57BL/6 mice

Psychopharmacology (Berl). 2017 Dec;234(23-24):3507-3520. doi: 10.1007/s00213-017-4738-y. Epub 2017 Sep 18.

Abstract

Rationale: Racemic (RS)-amisulpride (Solian®) is an atypical antipsychotic drug used to treat schizophrenia and dysthymia. Blockade of dopamine D2/D3 and/or serotonin 5-HT7 receptors is implicated in its pharmacological effects. While the (S)-amisulpride isomer possesses a robust discriminative cue, discriminative stimulus properties of (RS)-amisulpride have not been evaluated.

Objectives: The present study established (RS)-amisulpride as a discriminative stimulus and assessed amisulpride-like effects of amisulpride stereoisomers, other benzamide derivatives, and antipsychotic, antidepressant, and anxiolytic drugs.

Methods: Adult, male C57BL/6 mice were trained to discriminate 10 mg/kg (RS)-amisulpride from vehicle in a two-lever food-reinforced operant conditioning task.

Results: (RS)-Amisulpride's discriminative stimulus was dose-related, time-dependent, and stereoselective. (S)-Amisulpride (an effective dose of 50% (ED50) = 0.21 mg/kg) was three times more potent than (RS)-amisulpride (ED50 = 0.60 mg/kg) or (R)-amisulpride (ED50 = 0.68 mg/kg). (RS)-Amisulpride generalized fully to the structurally related atypical antipsychotic/antidysthymia drug sulpiride (Sulpor®; ED50 = 7.29 mg/kg) and its (S)-enantiomer (ED50 = 9.12 mg/kg); moderate to high partial generalization [60-75% drug lever responding (%DLR)] occurred to the benzamide analogs tiapride (Tiapridal®) and raclopride, but less than 60% DLR to metoclopramide (Reglan®), nemonapride (Emilace®), and zacopride. Antipsychotic, antidepressant, and antianxiety drugs from other chemical classes (chlorpromazine, quetiapine, risperidone, and mianserin) produced 35-55% amisulpride lever responding. Lastly, less than 35% DLR occurred for clozapine, olanzapine, aripiprazole imipramine, chlordiazepoxide, and bupropion.

Conclusions: (RS)-Amisulpride generalized to some, but not all benzamide derivatives, and it failed to generalize to any other antipsychotic, antidepressant, or antianxiety drugs tested. Interestingly, the (R)-isomer shared very strong stimulus properties with (RS)-amisulpride. This finding was in contrast to findings from Donahue et al. (Eur J Pharmacol 734:15-22, 2014), which found that the (R)-isomer did not share very strong stimulus properties when the (S)-isomer was the training drug.

Keywords: Amisulpride; Antidepressants; Antipsychotics; Anxiolytics; Benzamides; C57BL/6 mice; Discriminative stimulus; Drug discrimination; Isomers; Schizophrenia.

Publication types

  • Comparative Study

MeSH terms

  • Amisulpride
  • Animals
  • Anti-Anxiety Agents / chemistry
  • Anti-Anxiety Agents / pharmacology*
  • Antidepressive Agents / chemistry
  • Antidepressive Agents / pharmacology*
  • Antipsychotic Agents / chemistry
  • Antipsychotic Agents / pharmacology*
  • Benzamides / chemistry
  • Benzamides / pharmacology*
  • Chlorpromazine / chemistry
  • Chlorpromazine / pharmacology
  • Clozapine / chemistry
  • Clozapine / pharmacology
  • Conditioning, Operant / drug effects
  • Conditioning, Operant / physiology
  • Discrimination Learning / drug effects*
  • Discrimination Learning / physiology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Quetiapine Fumarate / chemistry
  • Quetiapine Fumarate / pharmacology
  • Risperidone / chemistry
  • Risperidone / pharmacology
  • Sulpiride / analogs & derivatives*
  • Sulpiride / chemistry
  • Sulpiride / pharmacology

Substances

  • Anti-Anxiety Agents
  • Antidepressive Agents
  • Antipsychotic Agents
  • Benzamides
  • Quetiapine Fumarate
  • Sulpiride
  • Amisulpride
  • Clozapine
  • Risperidone
  • Chlorpromazine